Cargando…

Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis

BACKGROUND: Previous meta-analyses have explored the association between the C677T polymorphism of methyltetrahydrofolate reductase (MTHFR) and chronic kidney disease (CKD) but there were no studies with a decisive conclusion. Furthermore, the high heterogeneity among different populations is not ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Hsueh-Lu, Chen, Guei-Rung, Hsiao, Po-Jen, Chiu, Chih-Chien, Tai, Ming-Cheng, Kao, Chung-Cheng, Tsai, Dung-Jang, Su, Hao, Chen, Yu-Hsuan, Chen, Wei-Teing, Su, Sui-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373545/
https://www.ncbi.nlm.nih.gov/pubmed/32702845
http://dx.doi.org/10.1097/MD.0000000000021045
_version_ 1783561513017016320
author Chang, Hsueh-Lu
Chen, Guei-Rung
Hsiao, Po-Jen
Chiu, Chih-Chien
Tai, Ming-Cheng
Kao, Chung-Cheng
Tsai, Dung-Jang
Su, Hao
Chen, Yu-Hsuan
Chen, Wei-Teing
Su, Sui-Lung
author_facet Chang, Hsueh-Lu
Chen, Guei-Rung
Hsiao, Po-Jen
Chiu, Chih-Chien
Tai, Ming-Cheng
Kao, Chung-Cheng
Tsai, Dung-Jang
Su, Hao
Chen, Yu-Hsuan
Chen, Wei-Teing
Su, Sui-Lung
author_sort Chang, Hsueh-Lu
collection PubMed
description BACKGROUND: Previous meta-analyses have explored the association between the C677T polymorphism of methyltetrahydrofolate reductase (MTHFR) and chronic kidney disease (CKD) but there were no studies with a decisive conclusion. Furthermore, the high heterogeneity among different populations is not yet interpreted. OBJECTIVES: This study used trial sequential analysis (TSA) to evaluate whether the nowadays conclusion supported by current cumulative samples. We also applied case-weighted meta-regression to explore the potential gene–environment interactions. METHODS: For the first stage of this study we conducted a case–control study involving 847 dialysis patients from 7 hemodialysis centers in Taipei during 2015 to 2018 and 755 normal controls from a health center in the Tri-Service General Hospital. The second stage combined the results from the first stage with previous studies. The previous studies were collected from PubMed, EMBASE, and Web of Science databases before January 2018. RESULTS: From the case–control study, the T allele of MTHFR C677T appeared to have a protective effect on end-stage renal disease compared with the C allele [odds ratio (OR): 0.80, 95% CI (confidence interval) = 0.69–0.93]. However, the meta-analysis contradicted the results in Asian (OR = 1.12, 95% CI = 0.96–1.30). The same analysis was also applied in Caucasian and presented similar results from Asian (OR = 1.18, 95% CI = 0.98–1.42). The TSA showed our case–control study to be the decisive sample leading to a null association among Asian population. The high heterogeneity (I(2) = 75%) could explain the contradictory results between the case–control study and the meta-analysis. However, further case-weighted meta-regression did not find any significant interaction between measured factors and MTHFR C677T on CKD. CONCLUSIONS: High heterogeneities were found in both Caucasian and Asian, which caused the null relationship in meta-analysis while there were significant effects in individual studies. Future studies should further explore the high heterogeneity that might be hidden in unmeasured gene–environment interactions, to explain the diverse findings among different populations.
format Online
Article
Text
id pubmed-7373545
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-73735452020-08-05 Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis Chang, Hsueh-Lu Chen, Guei-Rung Hsiao, Po-Jen Chiu, Chih-Chien Tai, Ming-Cheng Kao, Chung-Cheng Tsai, Dung-Jang Su, Hao Chen, Yu-Hsuan Chen, Wei-Teing Su, Sui-Lung Medicine (Baltimore) 4400 BACKGROUND: Previous meta-analyses have explored the association between the C677T polymorphism of methyltetrahydrofolate reductase (MTHFR) and chronic kidney disease (CKD) but there were no studies with a decisive conclusion. Furthermore, the high heterogeneity among different populations is not yet interpreted. OBJECTIVES: This study used trial sequential analysis (TSA) to evaluate whether the nowadays conclusion supported by current cumulative samples. We also applied case-weighted meta-regression to explore the potential gene–environment interactions. METHODS: For the first stage of this study we conducted a case–control study involving 847 dialysis patients from 7 hemodialysis centers in Taipei during 2015 to 2018 and 755 normal controls from a health center in the Tri-Service General Hospital. The second stage combined the results from the first stage with previous studies. The previous studies were collected from PubMed, EMBASE, and Web of Science databases before January 2018. RESULTS: From the case–control study, the T allele of MTHFR C677T appeared to have a protective effect on end-stage renal disease compared with the C allele [odds ratio (OR): 0.80, 95% CI (confidence interval) = 0.69–0.93]. However, the meta-analysis contradicted the results in Asian (OR = 1.12, 95% CI = 0.96–1.30). The same analysis was also applied in Caucasian and presented similar results from Asian (OR = 1.18, 95% CI = 0.98–1.42). The TSA showed our case–control study to be the decisive sample leading to a null association among Asian population. The high heterogeneity (I(2) = 75%) could explain the contradictory results between the case–control study and the meta-analysis. However, further case-weighted meta-regression did not find any significant interaction between measured factors and MTHFR C677T on CKD. CONCLUSIONS: High heterogeneities were found in both Caucasian and Asian, which caused the null relationship in meta-analysis while there were significant effects in individual studies. Future studies should further explore the high heterogeneity that might be hidden in unmeasured gene–environment interactions, to explain the diverse findings among different populations. Wolters Kluwer Health 2020-07-17 /pmc/articles/PMC7373545/ /pubmed/32702845 http://dx.doi.org/10.1097/MD.0000000000021045 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4400
Chang, Hsueh-Lu
Chen, Guei-Rung
Hsiao, Po-Jen
Chiu, Chih-Chien
Tai, Ming-Cheng
Kao, Chung-Cheng
Tsai, Dung-Jang
Su, Hao
Chen, Yu-Hsuan
Chen, Wei-Teing
Su, Sui-Lung
Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis
title Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis
title_full Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis
title_fullStr Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis
title_full_unstemmed Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis
title_short Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease: A case–control study and a meta-analysis
title_sort decisive evidence corroborates a null relationship between mthfr c677t and chronic kidney disease: a case–control study and a meta-analysis
topic 4400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373545/
https://www.ncbi.nlm.nih.gov/pubmed/32702845
http://dx.doi.org/10.1097/MD.0000000000021045
work_keys_str_mv AT changhsuehlu decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT chengueirung decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT hsiaopojen decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT chiuchihchien decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT taimingcheng decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT kaochungcheng decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT tsaidungjang decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT suhao decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT chenyuhsuan decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT chenweiteing decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis
AT susuilung decisiveevidencecorroboratesanullrelationshipbetweenmthfrc677tandchronickidneydiseaseacasecontrolstudyandametaanalysis